Meeting
2024 ASCO Annual Meeting
Genomic alterations in early-onset versus average-onset stage IV colorectal cancer.
Authors
Eric Michael Lander
Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
Eric Michael Lander , Samuel Rivero-Hinojosa , Vasily N. Aushev , Adham A Jurdi , Minetta C. Liu , Cathy Eng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 3586)
DOI
10.1200/JCO.2024.42.16_suppl.3586
Abstract #
3586
Poster Bd #
249
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Genomic classification of clinically advanced pancreatic ductal adenocarcinoma (PDAC) based on methylthioadenosine phosphorylase (MTAP) genomic loss (MTAP loss).
First Author: Natalie Ngoi
Poster
2018 ASCO Annual Meeting
The comparison of tumor mutational burden (TMB) in patients of early and late stage lung adenocarcinoma in China.
First Author: Kai Zhang
Poster
2013 ASCO Annual Meeting
Whole-exome sequencing in tumor samples from sequenom-wild-type, ALK negative stage IV lung adenocarcinoma (ADC) patients (p).
First Author: Enriqueta Felip
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comprehensive genomic profiling of advanced anal adenocarcinoma.
First Author: Nozomu Ogura